Meghan Scanlon, SVP, President, Urology Pelvic Health at BOSTON SCIENTIFIC CORP (BSX), sold 27,700 shares at $45.01 ($1.2M) on 2021-07-27, disclosed to the SEC on 2021-07-27.
Open-market sale of $1.2M BSX by SVP, President, Urology Pelvic Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 13,850 | $623K | 50.0% |
| 2 | $45.01 | 13,850 | $623K | 50.0% |
| Total | $45.01 avg | 27,700 | $1.2M | 100% |